Research output per year
Research output per year
Personal profile
Headline
PROFESSOR Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where John Roboz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
A classification model to predict the rate of decline of kidney function
Subasi, E., Subasi, M. M., Hammer, P. L., Roboz, J., Anbalagan, V. & Lipkowitz, M. S., 2017, In: Frontiers in Medicine. 4, JUL, 97.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
A classification model to predict the rate of decline of kidney function
Subasi, E., Subasi, M. M., Hammer, P. L., Roboz, J. & Lipkowitz, M., 2016.Research output: Contribution to conference › Paper › peer-review
-
The application of mass spectrometry to leukemia drug discovery
Roboz, G. J. & Roboz, J., 1 Nov 2016, In: Expert Opinion on Drug Discovery. 11, 11, p. 1029-1032 4 p.Research output: Contribution to journal › Editorial
Open Access2 Scopus citations -
C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients
Wang, X., Cho, S. Y., Hu, C. S., Chen, D., Roboz, J. & Hoffman, R., 1 Feb 2015, In: Experimental Hematology. 43, 2, p. 100-109.e1Research output: Contribution to journal › Article › peer-review
Open Access26 Scopus citations -
Mass spectrometry in leukemia research and treatment
Roboz, J. & Roboz, G. J., 1 Apr 2015, In: Expert Review of Hematology. 8, 2, p. 225-235 11 p.Research output: Contribution to journal › Review article › peer-review
6 Scopus citations
Press/Media
-
Mass Spectrometry – How a Mass Spectrometer Works, Types of Instrumentation and Interpreting Mass Spectral Data
4/05/21
2 items of Media coverage
Press/Media
-
Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition
6/11/18
1 item of Media coverage
Press/Media
-
Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition
5/11/18
2 items of Media coverage
Press/Media
-
Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition
5/11/18
4 items of Media coverage
Press/Media
-
Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition
5/11/18
1 item of Media coverage
Press/Media